1) Clinicians need information to provide quality care to patients, but have limited time and resources. Health information technology (IT) and health information exchange (HIE) can help provide clinicians with complete and timely patient information.
2) For HIE to be effective different health systems need to use common standards for exchanging patient data. Standards help ensure data is exchanged and understood across different technical systems and organizations.
3) The ultimate goals of HIE and health IT standards are to improve continuity of care, quality, safety, timeliness, effectiveness, equity, patient-centeredness and efficiency of healthcare.
This presentation provides an overview of the SIG TEL 4 Health that is located at the CELSTEC institute. We are cooperating with various medical partner organization in European projects on topics like patient safety and patient empowerment. We strongly believe that mobile solutions + semantic and analytic technologies will facilitated the empowered patient and health system of the future.
This presentation provides an overview of the SIG TEL 4 Health that is located at the CELSTEC institute. We are cooperating with various medical partner organization in European projects on topics like patient safety and patient empowerment. We strongly believe that mobile solutions + semantic and analytic technologies will facilitated the empowered patient and health system of the future.
An Introduction to Clinical InformaticsCorinn Pope
Why should you care about clinical informatics? Because those who practice clinical informatics just may help our healthcare system get out of its funk and become an efficient, lean, and tech-savvy machine. Plus, the industry is growing and growing fast.
Patient Safety and eHealth in the rescue: A revolution unfoldingMohammad Yeakub
Patient safety issues are increasing as practice of medicine gets more complex and expansive, and deserves utmost attention in controlling this exponentially growing challenge.
It was an honor to be invited to present the Clinical Informatics keynote at the Health Informatics Society of Australia's #HIC16 conference on July 25, 2016.
Here is an outline of the topics that I spoke about in greater depth with audience of Clinicians & IT execs.
(In a separate presentation I spoke of the importance of engaging Patients in healthcare design, patient generated data, self-care, crowdsourcing, etc)
Responding to the IOM Initiatives to Transform the BSN Program sarahswart
Institute of Medicine initiatives were used to transform the Bachelor of Science in Nursing Completion program. This presentation was delivered at a Nursing Summit meeting in 2005.
Presented at the 7th Healthcare CIO Program, Hospital Administration School, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand on July 8, 2016
Final Presentation of the Bergen Summer Research School 2010, course 4: Mobile Technologies for Global Health Research (presented on Friday, July 2 by Ali Habib, John Wesonga and Heather Zornetzer)
Medical Informatics: Computational Analytics in HealthcareNUS-ISS
Presented by Dr Liu Nan, Senior Research Scientist and Principal Investigator, Singapore General Hospital at ISS Seminar: How Analytics is Transforming Healthcare on 31 Oct 2014.
Effecting change by the use of emerging technologies in healthcare: A future vision for u-nursing in 2020
Michelle Honey, School of Nursing, University of Auckland, New Zealand
Karl Øyri, Interventional Centre, Rikshospitalet University Hospital, Oslo, Norway
Susan Newbold, Vanderbilt University School of Nursing, Nashville TN, USA
Amy Coenen, University of Wisconsin-Milwaukee College of Nursing, Milwaukee, WI, USA
Hyeoun-Ae Park, College of Nursing, Seoul National University, Seoul, Korea
Anneli Ensio, Department of Health Policy and Management, University of Kuopio, Finland
Elvio Jesus, Nursing Research Group of Madeira, Portugal
Presented at the 7th Healthcare CIO Program, Hospital Administration School, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand on July 8, 2016
Dr Sanjoy Sanyal wrote this article when he was doing his Masters in Royal College of Surgeons of Edinburgh, University of Bath, United Kingdom.
It traces the origin of the term and discipline called 'Medical Informatics'; describes its evolution and mentions its current healthcare applicability and academic status.
It is fundamental towards understanding today's Information Explosion and its digital implications in all work atmospheres.
Today Dr Sanjoy Sanyal is Professor and Course Director of Neuroscience and FCM-III in Caribbean.
An Introduction to Clinical InformaticsCorinn Pope
Why should you care about clinical informatics? Because those who practice clinical informatics just may help our healthcare system get out of its funk and become an efficient, lean, and tech-savvy machine. Plus, the industry is growing and growing fast.
Patient Safety and eHealth in the rescue: A revolution unfoldingMohammad Yeakub
Patient safety issues are increasing as practice of medicine gets more complex and expansive, and deserves utmost attention in controlling this exponentially growing challenge.
It was an honor to be invited to present the Clinical Informatics keynote at the Health Informatics Society of Australia's #HIC16 conference on July 25, 2016.
Here is an outline of the topics that I spoke about in greater depth with audience of Clinicians & IT execs.
(In a separate presentation I spoke of the importance of engaging Patients in healthcare design, patient generated data, self-care, crowdsourcing, etc)
Responding to the IOM Initiatives to Transform the BSN Program sarahswart
Institute of Medicine initiatives were used to transform the Bachelor of Science in Nursing Completion program. This presentation was delivered at a Nursing Summit meeting in 2005.
Presented at the 7th Healthcare CIO Program, Hospital Administration School, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand on July 8, 2016
Final Presentation of the Bergen Summer Research School 2010, course 4: Mobile Technologies for Global Health Research (presented on Friday, July 2 by Ali Habib, John Wesonga and Heather Zornetzer)
Medical Informatics: Computational Analytics in HealthcareNUS-ISS
Presented by Dr Liu Nan, Senior Research Scientist and Principal Investigator, Singapore General Hospital at ISS Seminar: How Analytics is Transforming Healthcare on 31 Oct 2014.
Effecting change by the use of emerging technologies in healthcare: A future vision for u-nursing in 2020
Michelle Honey, School of Nursing, University of Auckland, New Zealand
Karl Øyri, Interventional Centre, Rikshospitalet University Hospital, Oslo, Norway
Susan Newbold, Vanderbilt University School of Nursing, Nashville TN, USA
Amy Coenen, University of Wisconsin-Milwaukee College of Nursing, Milwaukee, WI, USA
Hyeoun-Ae Park, College of Nursing, Seoul National University, Seoul, Korea
Anneli Ensio, Department of Health Policy and Management, University of Kuopio, Finland
Elvio Jesus, Nursing Research Group of Madeira, Portugal
Presented at the 7th Healthcare CIO Program, Hospital Administration School, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand on July 8, 2016
Dr Sanjoy Sanyal wrote this article when he was doing his Masters in Royal College of Surgeons of Edinburgh, University of Bath, United Kingdom.
It traces the origin of the term and discipline called 'Medical Informatics'; describes its evolution and mentions its current healthcare applicability and academic status.
It is fundamental towards understanding today's Information Explosion and its digital implications in all work atmospheres.
Today Dr Sanjoy Sanyal is Professor and Course Director of Neuroscience and FCM-III in Caribbean.
Presented at the Data Science for Healthcare Graduate Programs, Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on October 7, 2019
What you need to know about Meaningful Use 2 & interoperabilityCompliancy Group
Does this describe you?
·You are constantly challenged to stay abreast of the latest information on EHR integration and HIE interoperability, Meaningful Use stages, the Direct Project, clinician and patient portals, just to name a few.
·You walk a fine line between adopting health information technology for the good it can bring patient outcomes…….and for the good incentive dollars it can mean to your organization.
·You play a key role in ensuring your organization can attest for meaningful use.
Join Andy Nieto, Health IT Strategist at DataMotion where he’ll explain the key role that interoperability plays in Meaningful Use Stage 2 attestation including:
- What does interoperability really mean
- Why you can’t ignore interoperability
- How to achieve interoperability and make it meaningful
- What you need in order to attest
Presented at the Master of Science and Doctor of Philosophy Programs in Data Science for Healthcare and Clinical Informatics, Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on October 4, 2021
Introduction to Health Informatics and Health IT (Part 2) (February 10, 2021)Nawanan Theera-Ampornpunt
Presented at the 11th Healthcare CIO Certificate Program, School of Hospital Management, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on February 10, 2021
Presented at the 8th Healthcare CIO Certificate Program, Ramathibodi Hospital Administration School, Faculty of Medicine Ramathibodi Hospital, Mahidol University on March 12, 2018
Introduction to Health Informatics and Health IT in Clinical Settings (Part 2...Nawanan Theera-Ampornpunt
Presented at the 10th Healthcare CIO Certificate Program, Ramathibodi School of Hospital Management, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on February 17, 2020
Presented at the Master of Science and Doctor of Philosophy Programs in Data Science for Healthcare and Clinical Informatics, Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on October 12, 2020
Presented at the 9th Healthcare CIO Certificate Program, School of Hospital Management, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on March 4, 2019
Presented at the BDMS Golden Jubilee Scientific Conference 2022 "BDMS Beyond 50 years: Looking towards the centennial," Bangkok Dusit Medical Services Public Company Limited (BDMS), Bangkok, Thailand on October 19, 2022
Presented at The Thai Medical Informatics Association Annual Conference and The National Conference on Medical Informatics (TMI-NCMedInfo) 2021, Bangkok, Thailand on November 26, 2021
Presented at the Master of Science Program in Medical Epidemiology and the Doctor of Philosophy Program in Clinical Epidemiology, Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on November 25, 2021
Presented at the Master of Science and Doctor of Philosophy Programs in Data Science for Healthcare and Clinical Informatics, Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on November 15, 2021
Consumer Health Informatics, Mobile Health, and Social Media for Health: Part...Nawanan Theera-Ampornpunt
Presented at the Master of Science and Doctor of Philosophy Programs in Data Science for Healthcare and Clinical Informatics, Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand on November 10, 2021
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Medical Information Exchange in ASEAN Countries: How To Achieve IT?
1. 1
Nawanan Theera-Ampornpunt, M.D., Ph.D.
Faculty of Medicine Ramathibodi Hospital
Mahidol University
October 8, 2013
Medical Information Exchange
in ASEAN Countries:
How to Achieve It?
www.SlideShare.net/Nawanan
3. 3
What Clinicians Want?
To treat & to
care for their
patients to their
best abilities,
given limited
time &
resources
Image Source: http://en.wikipedia.org/wiki/File:Newborn_Examination_1967.jpg (Nevit Dilmen)
4. 4
High Quality Care
• Safe
• Timely
• Effective
• Efficient
• Equitable
• Patient-Centered
Institute of Medicine, Committee on Quality of Health Care in
America. Crossing the quality chasm: a new health system for the
21st century. Washington, DC: National Academy Press; 2001. 337 p.
5. 5
Information is Everywhere in Medicine
Shortliffe EH. Biomedical informatics in the education of
physicians. JAMA. 2010 Sep 15;304(11):1227-8.
6. 6
Achieving Quality Care with Information
• Safe
– Drug allergies
– Medication Reconciliation
• Timely
– Complete information at point of care
• Effective
– Better clinical decision-making
Image Source: http://www.flickr.com/photos/childrensalliance/3191862260/
7. 7
Achieving Quality Care with Information
• Efficient
– Faster care
– Time & cost savings
– Reducing unnecessary tests
• Equitable
– Access to providers & knowledge
• Patient-Centered
– Empowerment & better self-care
9. 9
The Anatomy of Health IT
Health
Information
Technology
Goal
Value‐Add
Means
10. 10
Various Forms of Health IT
Hospital Information System
(HIS)
Computerized Provider Order Entry
(CPOE)
Electronic
Health
Records
(EHRs)
Picture Archiving and
Communication
System (PACS)
11. 11
Still Many Other Forms of Health IT
m-Health
Health Information
Exchange (HIE)
Biosurveillance
Information Retrieval
Telemedicine &
Telehealth
Personal Health Records
(PHRs)
Image Sources: Apple Inc., Geekzone.co.nz, Google, Microsoft, PubMed.gov, and American Telecare, Inc.
13. 13
eHealth & Health Information Exchange
Hospital A Hospital B
Clinic C
Government
Lab Patient at
Home
14. 14
Goals of Health Information Exchange
• Deliver patient’s health information
across systems & settings
• To support high-quality health care
delivery by providers
• As well as facilitating other health
care functions (patient’s access,
reimbursements, public health
operations, policy-making, education,
research)
17. 17
Standards: Why?
• The Large N Problem
N = 2, Interface = 1
# Interfaces = N(N-1)/2
N = 3, Interface = 3
N = 5, Interface = 10
N = 100, Interface = 4,950
18. 18
eHealth & Health Information Exchange
Hospital A Hospital B
Clinic C
Government
Lab Patient at
Home
21. 21
How Standards Support Interoperability
Technical Standards
(TCP/IP, encryption, security)
Exchange Standards
(HL7 v.2, HL7 v.3 Messaging,
HL7 CDA, DICOM)
Vocabularies, Terminologies,
Coding Systems (ICD-10, ICD-9,
CPT, SNOMED CT, LOINC)
Information Models
(HL7 v.3 RIM, ASTM CCR, HL7 CCD)
Standard Data Sets (12 & 18 Files)
Functional Standards (HL7 EHR
Functional Specifications)
Some may be hybrid: e.g. HL7 v.3, HL7 CCD
Unique ID (Provider, Facility, Patient)
Functional
Semantic
Syntactic
22. 22
An Example: SNOMED CT
• A coded clinical terminology for use
in Electronic Health Records
• Currently maintained by IHTSDO
• Each concept has a code, a name
(“term”) and relationships with other
concepts
23. 23
Concepts & Relationships in SNOMED CT
Source: http://ihtsdo.org/fileadmin/user_upload/Docs_01/Publications/SNOMED_CT/SnomedCt_Intro_20130418.pdf
26. 26
Patients Are Counting on Us...
Image Source: http://www.flickr.com/photos/childrensalliance/3191862260/
27. 27
Summary
• Better information means quality of care
• Health IT helps clinicians care for patients
• Health Information Exchange (HIE) should be
our shared VISION
• Standards help us achieve HIE, and thus better
care
• There are many types of standards needed to
achieve HIE, including SNOMED CT
• Let’s walk together toward that common goal,
for the benefits of patients and all stakeholders